These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 19194365

  • 1. Review: Daptomycin for the treatment of gram-positive infections in neutropenic cancer patients.
    Rolston KV.
    Clin Adv Hematol Oncol; 2008 Nov; 6(11):815-7. PubMed ID: 19194365
    [No Abstract] [Full Text] [Related]

  • 2. Daptomycin for soft tissue infection and neutropenia in a myelogenous leukemia patient who failed prior vancomycin therapy.
    Sakoulas G.
    Clin Adv Hematol Oncol; 2008 Nov; 6(11):813-5. PubMed ID: 19194364
    [No Abstract] [Full Text] [Related]

  • 3. Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia.
    Jacobson LM, Milstone AM, Zenilman J, Carroll KC, Arav-Boger R.
    Pediatr Infect Dis J; 2009 May; 28(5):445-7. PubMed ID: 19295462
    [Abstract] [Full Text] [Related]

  • 4. Variable daptomycin susceptibility in patients receiving intravenous vancomycin for meticillin-resistant Staphylococcus aureus infections.
    Golden M, Shaib W, Havill N.
    Int J Antimicrob Agents; 2010 Mar; 35(3):306-8. PubMed ID: 20036108
    [No Abstract] [Full Text] [Related]

  • 5. [The second life of daptomycin: analysis of a successful come-back].
    Decousser JW, Doucet Populaire F.
    Med Mal Infect; 2008 Dec; 38 Spec No 2():1-3. PubMed ID: 19185200
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of mitral MRSA endocarditis using daptomycin].
    Senneville E, Beltrand E, Legout L, Leroy O, Fayad G.
    Med Mal Infect; 2008 Dec; 38 Spec No 2():13-5. PubMed ID: 19185204
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of resistant Gram-positive bacterial infections].
    Lenoble M.
    Med Mal Infect; 2011 Sep; 41(9 Suppl):1-6. PubMed ID: 22133738
    [No Abstract] [Full Text] [Related]

  • 8. Clinical activity of anti-Gram-positive agents against methicillin-resistant Staphylococcus aureus.
    Gould IM.
    J Antimicrob Chemother; 2011 May; 66 Suppl 4():iv17-iv21. PubMed ID: 21521703
    [Abstract] [Full Text] [Related]

  • 9. Fatal bacteraemia caused by daptomycin-non-susceptible, vancomycin-intermediate, meticillin-resistant Staphylococcus aureus in a patient with chronic kidney disease.
    Kuo CC, Wu VC, Huang YT, Liao CH, Hsueh PR.
    Int J Antimicrob Agents; 2009 Jan; 33(1):96-8. PubMed ID: 18790610
    [No Abstract] [Full Text] [Related]

  • 10. Daptomycin use after vancomycin-induced neutropenia in a patient with left-sided endocarditis.
    Mergenhagen KA, Pasko MT.
    Ann Pharmacother; 2007 Sep; 41(9):1531-5. PubMed ID: 17652126
    [Abstract] [Full Text] [Related]

  • 11. Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis.
    Vernadakis S, Saner FH, Rath PM, Kaiser GM, Mathe Z, Treckmann J, Paul A.
    Transpl Infect Dis; 2009 Aug; 11(4):346-8. PubMed ID: 19497075
    [Abstract] [Full Text] [Related]

  • 12. Telavancin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
    Twilla JD, Gelfand MS, Cleveland KO, Usery JB.
    J Antimicrob Chemother; 2011 Nov; 66(11):2675-7. PubMed ID: 21831987
    [No Abstract] [Full Text] [Related]

  • 13. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections.
    Deresinski S.
    Clin Infect Dis; 2009 Oct 01; 49(7):1072-9. PubMed ID: 19725789
    [Abstract] [Full Text] [Related]

  • 14. Presence of adequate intravitreal concentrations of daptomycin after systemic intravenous administration in a patient with endogenous endophthalmitis.
    Sheridan KR, Potoski BA, Shields RK, Nau GJ.
    Pharmacotherapy; 2010 Dec 01; 30(12):1247-51. PubMed ID: 21114392
    [Abstract] [Full Text] [Related]

  • 15. Cost-Effectiveness of daptomycin versus vancomycin and gentamicin for patients with methicillin-resistant Staphylococcus aureus bacteremia and/or endocarditis.
    Bhavnani SM, Prakhya A, Hammel JP, Ambrose PG.
    Clin Infect Dis; 2009 Sep 01; 49(5):691-8. PubMed ID: 19635023
    [Abstract] [Full Text] [Related]

  • 16. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis.
    Gerber P, Stucki A, Acosta F, Cottagnoud M, Cottagnoud P.
    J Antimicrob Chemother; 2006 Apr 01; 57(4):720-3. PubMed ID: 16459345
    [Abstract] [Full Text] [Related]

  • 17. [Osteomyelitis associated with Staphylococcus aureus infection and reduced susceptibility to vancomycin treated with daptomycin].
    Araujo F, Conde Estevez D, Encinas Barrios C.
    Farm Hosp; 2012 Apr 01; 36(5):449-51. PubMed ID: 22484104
    [No Abstract] [Full Text] [Related]

  • 18. Empirical therapy for serious Gram-positive infections: making the right choice.
    Segreti J.
    Clin Microbiol Infect; 2009 Dec 01; 15 Suppl 6():5-10. PubMed ID: 19917021
    [Abstract] [Full Text] [Related]

  • 19. Therapy for methicillin-resistant Staphylococcus aureus.
    Torres-Tortosa M, Caballero-Granado FJ, Canueto J.
    N Engl J Med; 2006 Nov 16; 355(20):2153-4; author reply 2155. PubMed ID: 17120350
    [No Abstract] [Full Text] [Related]

  • 20. Therapy for methicillin-resistant Staphylococcus aureus.
    Siegman-Igra Y, Talan DA.
    N Engl J Med; 2006 Nov 16; 355(20):2153; author reply 2155. PubMed ID: 17108348
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.